Lívia Bracht

Dr. Lívia Bracht

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2019 in Toxicology Letters
Verified
Journal Article
Closed access
GSGabriela Bueno Franco Salla
Gabriela Bueno Franco Salla
LBLívia Bracht
Lívia Bracht
APAngela Valderrama Parizotto
Angela Valderrama Parizotto
JCJurandir F. Comar
Jurandir F. Comar
Rosane PeraltaRosane Peralta
Rosane Peralta
ABAdelar Bracht
Adelar Bracht

10 August 2022 in Toxicology Letters
Verified
Journal Article
Closed access
EMEvelyn Silva Moreira
Evelyn Silva Moreira
AAAna Paula Ames-Sibin
Ana Paula Ames-Sibin
CBCarla Indianara Bonetti
Carla Indianara Bonetti
LLLuana Eloísa Leal
Luana Eloísa Leal
RPRosane Marina Peralta
Rosane Marina Peralta
LBLívia Bracht
Lívia Bracht

14 March 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
RCRhaira Fernanda Ayoub Casalvara
Rhaira Fernanda Ayoub Casalvara
Bruna Mayara Roldão FerreiraBruna Mayara Roldão Ferreira
Bruna Mayara Roldão Ferreira
José Eduardo GonçalvesJosé Eduardo Gonçalves
José Eduardo Gonçalves
Natália Ueda YamaguchiNatália Ueda Yamaguchi
Natália Ueda Yamaguchi
ABAdelar Bracht
Adelar Bracht
Rosane PeraltaRosane Peralta
Rosane Peralta
This study aimed to provide an updated critical review of the nutritional, therapeutic, biotechnological, and environmental aspects involved in the exploitation of Chenopodium quinoa Willd and its biowastes. Special attention was devoted to investigations of the therapeutic and nutritional properties of different parts and varieties of quinoa as well as of the use of the biowaste resulting from the processing of grain. Studies published from 2018 onward were prioritized. Extracts and fractions obtained from several Chenopodium quinoa matrices showed antioxidant, antidiabetic, immunoregulatory, neuroprotective, and antimicrobial effects in in vitro and in vivo models and some clinical studies. The activities were attributed to the presence of phytochemicals such as polyphenols, saponins, peptides, polysaccharides, and dietary fibers. Quinoa wastes are abundant and low-cost sources of bioactive molecules for the development of new drugs, natural antioxidants, preservatives, dyes, emulsifiers, and carriers for food and cosmetics applications. Among the demands to be fulfilled in the coming years are the following: (1) isolation of new bioactive phytochemicals from quinoa varieties that are still underexploited; (2) optimization of green approaches to the sustainable recovery of compounds of industrial interest from quinoa by-products; and (3) well-conducted clinical trials to attest safety and efficacy of extracts and compounds.

19 December 2023 in Food Research International
Verified
Journal Article
Closed access
AOAnielle de Oliveira
Anielle de Oliveira
TMThaysa Fernandes Moya Moreira
Thaysa Fernandes Moya Moreira
BSBeatriz Paes Silva
Beatriz Paes Silva
GOGrazielle Oliveira
Grazielle Oliveira
VTValéria Maria C. Teixeira
Valéria Maria C. Teixeira
JCJurandir F. Comar
Jurandir F. Comar

15 October 2019 in Antioxidants
Verified
Journal Article
Open access
PDF file
HPHeloisa V. Pereira-Maróstica
Heloisa V. Pereira-Maróstica
LCLorena S. Castro
Lorena S. Castro
GGGeferson Gonçalves
Geferson Gonçalves
FSFrancielli M.S. Silva
Francielli M.S. Silva
LBLívia Bracht
Lívia Bracht
ANAnacharis Nakanishi
Anacharis Nakanishi
Methyl jasmonate (MeJA), common in the plant kingdom, is capable of reducing articular and hepatic inflammation and oxidative stress in adjuvant-induced arthritic rats. This study investigated the actions of orally administered MeJA (75–300 mg/kg) on inflammation, oxidative stress and selected enzyme activities in the brain of Holtzman rats with adjuvant-induced arthritis. MeJA prevented the arthritis-induced increased levels of nitrites, nitrates, lipid peroxides, protein carbonyls and reactive oxygen species (ROS). It also prevented the enhanced activities of myeloperoxidase and xanthine oxidase. Conversely, the diminished catalase and superoxide dismutase activities and glutathione (GSH) levels caused by arthritis were totally or partially prevented. Furthermore, MeJA increased the activity of the mitochondrial isocitrate dehydrogenase, which helps to supply NADPH for the mitochondrial glutathione cycle, possibly contributing to the partial recovery of the GSH/oxidized glutathione (GSSG) ratio. These positive actions on the antioxidant defenses may counterbalance the effects of MeJA as enhancer of ROS production in the mitochondrial respiratory chain. A negative effect of MeJA is the detachment of hexokinase from the mitochondria, which can potentially impair glucose phosphorylation and metabolism. In overall terms, however, it can be concluded that MeJA attenuates to a considerable extent the negative effects caused by arthritis in terms of inflammation and oxidative stress.

3 July 2023 in Naunyn-Schmiedeberg's Archives of Pharmacology
Verified
Journal Article
Closed access
PDF file
LLLuana Eloísa Leal
Luana Eloísa Leal
EMEvelyn Silva Moreira
Evelyn Silva Moreira
BCBruna Lopes Correia
Bruna Lopes Correia
PBPaulo Sérgio Alves Bueno
Paulo Sérgio Alves Bueno
JCJurandir Fernando Comar
Jurandir Fernando Comar
LBLívia Bracht
Lívia Bracht